Oncology Collection (page 9)

Intestinal tumour, artwork C015 / 6451
Intestinal tumour. Computer artwork of a tumour on the internal wall of an intestine

Lung cancer, X-ray C017 / 7964
Lung cancer. X-ray if the chest of a patient with malignant (cancerous) tumours in middle of the left lung (seen at right). The main cause of lung cancer is cigarette smoke

Chronic myeloid leukaemia, micrograph C015 / 6227
Chronic myeloid leukaemia. Light micrograph of bone marrow from a patient with chronic myeloid leukaemia (CML). This cancer affects the myeloid tissue (bone marrow)

Acute myeloid leukaemia C015 / 6225
Acute myeloid leukaemia. Light micrograph of bone marrow from a patient with acute myeloid leukaemia (AML). This cancer affects the myeloid tissue (bone marrow)

Methyltransferase complexed with DNA C015 / 6425
Methyltransferase complexed with DNA, molecular model. The strand of DNA (deoxyribonucleic acid, red and green) is enclosed by DNA methyltransferase 1 (DNMT-1, brown)

Methyltransferase complexed with DNA C015 / 6424
Methyltransferase complexed with DNA, molecular model. The strand of DNA (deoxyribonucleic acid, red and pink) is enclosed by DNA methyltransferase 1 (DNMT-1, blue)

Chromatin remodelling factor and DNA C015 / 5156
Chromatin remodelling factor and DNA, molecular model. The strands of DNA (deoxyribonucleic acid) are at left and right (both red and green). This chromatin remodelling factor (purple) is ISW1a

Spleen cancer, gross specimen C015 / 6421
Spleen cancer. Gross specimen of a spleen showing a large lymphosarcoma, or non-Hodgkins lymphoma, a cancer of lymphoid tissue. The lymphatic system is a major part of the immune system

Chromatin remodelling factor and DNA C015 / 5155
Chromatin remodelling factor and DNA, molecular model. The strands of DNA (deoxyribonucleic acid) are at left and right (pink-yellow and green-orange). This chromatin remodelling factor is ISW1a

Tumour embolism, light micrograph C015 / 6397
Tumour embolism. Light micrograph of a section through an embolism (blood clot) caused by cells from a cervical cancer. The cells have left the primary tumour and are metastasising (spreading)

Mesothelioma lung cancer, X-ray C017 / 7776
Mesothelioma lung cancer, X-ray of the chest of a 84 year old male patient with advanced mesothelioma, a type of lung cancer

Angiosarcoma of the spleen C015 / 6398
Angiosarcoma. Gross specimen of a sectioned spleen affected by angiosarcoma. Malignant (cancerous) tumours (yellow) can be seen at bottom centre

Secondary pancreatic cancer, ultrasound C017 / 7765
Secondary pancreatic cancer. Ultrasound scan of a 63 year old male patients pancreas showing metastatic (secondary) tumours. The cancer has metastasised (spread) from a primary cancer

Secondary thyroid cancer C015 / 6170
Secondary thyroid cancer. Light micrograph of a section through a tumour in a lymph node due to a secondary thyroid cancer

Alveolar soft part sarcoma, TEM C016 / 5826
Alveolar soft part sarcoma. Transmission electron micrograph (TEM) of a section through an alveolar soft part sarcoma (ASPS) showing a characteristic rhomboid crystal (black, centre)

Alveolar soft part sarcoma, TEM C016 / 5816
Alveolar soft part sarcoma. Transmission electron micrograph (TEM) of a section through an alveolar soft part sarcoma (ASPS) showing a characteristic rhomboid crystal (black)

Breast cancer protein and cancer cell C016 / 4613
Artwork showing a molecular model of breast cancer type 1 susceptibility (BRCA1) protein (left) and a cancer cell (right)

Breast cancer protein and cancer cell C016 / 4612
Artwork showing a molecular model of breast cancer type 1 susceptibility (BRCA1) protein (left) and a cancer cell (right)

Breast cancer protein and cancer cell C016 / 4610
Artwork showing a molecular model of breast cancer type 1 susceptibility (BRCA1) protein (left) and a cancer cell (right)

Breast cancer protein and cancer cell C016 / 4608
Artwork showing a molecular model of breast cancer type 1 susceptibility (BRCA1) protein (left) and a cancer cell (right)

Breast cancer and cancer protein molecule C016 / 4604
Breast cancer. Wireframe computer artwork of a woman with breast cancer. There is a malignant (cancerous) tumour (pink) in the patients right breast

Breast cancer protein and cancer cell C016 / 4600
Artwork showing a molecular model of breast cancer type 1 susceptibility (BRCA1) protein (left) and a cancer cell (right)

Breast cancer protein and cancer cell C016 / 4598
Artwork showing a molecular model of breast cancer type 1 susceptibility (BRCA1) protein (left) and a cancer cell (right)

Breast cancer protein molecule C016 / 4455
Breast cancer protein. Molecular model of breast cancer type 1 susceptibility (BRCA1) protein. This protein is found in breast and other tissue

Breast cancer protein molecule C016 / 4454
Breast cancer protein. Molecular model of breast cancer type 1 susceptibility (BRCA1) protein. This protein is found in breast and other tissue

Breast cancer protein molecule C016 / 4453
Breast cancer protein. Molecular model of breast cancer type 1 susceptibility (BRCA1) protein. This protein is found in breast and other tissue

Breast cancer protein molecule C016 / 4450
Breast cancer protein. Molecular model of breast cancer type 1 susceptibility (BRCA1) protein. This protein is found in breast and other tissue

Brain cancer, MRI scan C016 / 4438
Brain cancer. Coloured coronal magnetic resonance imaging (MRI) scan through the head of a 48 year old male patient with a glioblastoma (red)

Brain cancer, MRI scan C016 / 4436
Brain cancer. Coloured coronal magnetic resonance imaging (MRI) scan through the head of a 48 year old male patient with a glioblastoma (centre right)

Brain cancer, MRI scan C016 / 4437
Brain cancer. Coloured coronal magnetic resonance imaging (MRI) scan through the head of a 48 year old male patient with a glioblastoma (orange)

Lung cancer, X-ray C016 / 4435
Lung cancer. Coloured chest X-ray of a 64 year old male patient with lung cancer. The tumour is seen as the red mass in the right lung (bright area at left)

Lung cancer, X-ray C016 / 4432
Lung cancer. Coloured chest X-ray of a 64 year old male patient with lung cancer. The tumour is seen as the orange mass in the right lung (dark area at left)

Lung cancer, X-ray C016 / 4433
Lung cancer. Coloured chest X-ray of a 64 year old male patient with lung cancer. The tumour is seen as the orange mass in the right lung (bright area at left)

H-Ras p21 oncogene protein C016 / 2833
H-Ras p21 oncogene protein, molecular model. The Ras proteins are involved in transmitting signals within cells. Excessive signalling can lead to conditions such as cancer

H-Ras p21 oncogene protein C016 / 2832
H-Ras p21 oncogene protein, molecular model. The Ras proteins are involved in transmitting signals within cells. Excessive signalling can lead to conditions such as cancer

Human tumour protein p73 C016 / 2830
Human tumour protein p73. Molecular model of the human tumour protein p73, encoded by the TP73 gene. Like the similar p53, is is a transcription factor of a type known as a tumour suppressor gene

Human tumour protein p73 C016 / 2831
Human tumour protein p73. Molecular model of the human tumour protein p73, encoded by the TP73 gene. Like the similar p53, is is a transcription factor of a type known as a tumour suppressor gene

Human tumour protein p63 C016 / 2681
Human tumour protein p63. Molecular model of the tetramerization domain of the human tumour protein p63, encoded by the TP63 gene

Human tumour protein p63 C016 / 2680
Human tumour protein p63. Molecular model of the tetramerization domain of the human tumour protein p63, encoded by the TP63 gene

DNA and tumour suppressor complex C014 / 0014
DNA and tumour suppressor complex. Molecular model showing a molecule of the p53 tumour suppressor protein (green, centre) bound to a damaged DNA (deoxyribonucleic acid) strand

Preventing cancer spreading, artwork C013 / 8816
Preventing cancer spreading, conceptual artwork. Cancer cells inside a geodesic cage, representing the prevention of metastasis - spreading to other tissues of the body

Angiogenesis inhibitors, conceptual image C013 / 7789
Angiogenesis inhibitors, conceptual image. Computer artwork showing a brick wall preventing new blood vessels from reaching a cancerous tumour

Bexarotene chemotherapy drug molecule C013 / 7785
Bexarotene chemotherapy drug molecule. Computer model showing the structure of a molecule of the antineoplastic drug bexarotene (C24H28O2)

Bexarotene chemotherapy drug molecule C013 / 7784
Bexarotene chemotherapy drug molecule. Computer model showing the structure of a molecule of the antineoplastic drug bexarotene (C24H28O2)

Radiotherapy treatment C014 / 0164
Radiotherapy treatment. Cancer patient positioned under a linear accelerator in a radiotherapy suite. Linear accelerators are used to produce radiation to treat cancer

Lung cancer cell division, artwork C013 / 4630
Lung cancer cell division. Computer artwork of a lung cancer cell during cell division (cytokinesis). The two daughter cells remain temporarily joined by a cytoplasmic bridge (centre)

Cancer cell, artwork C013 / 4622
Cancer cell. Computer artwork of a single typical cancer cell in the human body. The uneven surface and cytoplasmic projections are characteristic of cancer cells

Blood cancer, conceptual image C013 / 4618
Blood cancer, conceptual image. Computer artwork of the interior of a blood vessel, showing cancer cells (dark) amongst normal red blood cells (red)

All Professionally Made to Order for Quick Shipping

Oncology: Unveiling the Battle Within In the realm of oncology, a fierce war is waged between T lymphocytes and cancer cells. SEM C001 / 1679 captures this epic struggle at a microscopic level, showcasing the intricate dance between these two adversaries. HeLa cells, depicted in light micrographs C017 / 8299 and C017 / 8298, offer us glimpses into their mysterious world. These immortal cells have played an instrumental role in countless scientific breakthroughs, unraveling the secrets of cancer biology. Acute promyelocytic leukemia reveals its sinister face through a haunting micrograph. The image serves as a reminder of the relentless fight against blood cancers that oncologists tirelessly engage in each day. Ovarian cancer's treacherous nature is exposed under the lens of light micrograph C015 / 7103. This glimpse into its cellular landscape fuels our determination to develop effective treatments for this formidable disease. The paclitaxel drug molecule emerges as a potent weapon in our arsenal against cancer. Its molecular structure holds promise for patients battling various forms of malignancies. Within operating rooms worldwide, surgeons skillfully navigate breast cancer cases with precision and expertise. Armamentarii Chirurgici provides us with an intimate view into these life-saving procedures. Cancerous scrofula reminds us that skin diseases can also be harbingers of deeper battles within our bodies. Description des Maladies de la Peau offers insight into dermatological manifestations linked to underlying malignancies. Traite Complet de l'Anatomie de l unveils surgical interventions on malignant tumors – visual proof that medical professionals are at the forefront of combating this pervasive disease. Medical illustrations depicting pilonidal cysts near the natal cleft or stages of colon cancer serve as educational tools to raise awareness about lesser-known aspects while empowering individuals to seek timely medical intervention.